LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
Halozyme Therapeutics
HALO
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
YETI Holdings
YETI
Dorian LPG
LPG
US Stock MarketDetailed Quotes
DNAY Codex DNA
- 1.300
- 0.0000.00%
Close Jan 3 16:00 ET
39.13MMarket Cap-0.99P/E (TTM)
0.000High0.000Low0Volume0.000Open1.300Pre Close0.00Turnover0.00%Turnover RatioLossP/E (Static)30.10MShares1.30952wk High2.20P/B9.79MFloat Cap1.20052wk Low--Dividend TTM7.53MShs Float25.700Historical High--Div YieldTTM0.00%Amplitude1.080Historical Low--Avg Price1Lot Size
Codex DNA Key Stats
EPS
According to the latest financial report of Codex DNA, the latest earnings per share (TTM) for the company is -0.42. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about Codex DNA's free cash flow? The latest report shows it as -15.49M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Codex DNA shows that the company's current ratio is 4.86, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Codex DNA, the quick ratio is 4.33, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of Codex DNA? The latest ROE figure is -20.87%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Codex DNA, the total asset return on investment (ROA) is -13.28%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Codex DNA's latest financial report to see how their gross margin is doing - currently at 54.82%.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Codex DNA, the net profit margin is -184.48%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...